MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Gait disorders: Treatment"

  • 2025 International Congress

    Effect of Sensory Feedback Vibration Stimulation Using an In-Sole Foot Pressure Monitor on Gait

    K. Kakegawa, T. Matsuda, J. Ogawa, Y. Yamaguchi, K. Fujinawa (Bunkyo-ku, Tokyo, Japan)

    Objective: To investigate the effects of a sensory feedback vibration stimulation device that integrates an insole foot pressure sensor on gait. Background: Foot pressure during…
  • 2025 International Congress

    Freezing of Gait Detection and Warning System for Parkinson’s Patients

    D. Kusbeci, T. Ozkarslioglu, N. Durmaz Celik, Z. Saatci (Izmir, Turkey)

    Objective: This study aims to mitigate the adverse effects of FOG through a novel, wearable device designed for real-time detection and intervention. Background: One of…
  • 2024 International Congress

    A Phase 2 Randomized Clinical Trial of TAK-071, an Acetylcholine M1 Receptor Positive Allosteric Modulator, in Parkinson Disease with Cognitive Impairment

    N. Shanbhag, J. Padmanabhan, Z. Zhang, B. Harel, H. Jia, T. Kangarloo, W. Yin, A. Dowling, A. Laurenza, P. Khudyakov, K. Galinksy, R. Latzman, T. Simuni, D. Weintraub, F. Horak, C. Lustig, P. Maruff, A. Simen (Cambridge, USA)

    Objective: To study the safety and efficacy of TAK-071, an M1 positive allosteric modulator, in adults with Parkinson disease (PD) with increased risk for falls…
  • 2024 International Congress

    Effects of Mental Practice on FOG in People with Parkinson’s Disease: a Randomized Clinical Trial

    P. Silva, K. Honda, I. Nascimento, K. Nobrega, N. Pereira, T. Barolli (Sao Paulo, Brazil)

    Objective: To compare the effects of an experimental intervention (EI) based on NCI with a control intervention (CI) of equal volume and intensity, differing only…
  • 2024 International Congress

    Effect of Tactile Cueing on Dual Task Performance in Parkinson’s Disease-A Systematic Review and Meta-Analysis

    V. Azoidou, A J. Noyce, C. Simonet (London, United Kingdom)

    Objective: This systematic review and meta-analysis were performed to examine the effect of tactile cueing on dual task (DT) performance in adults with idiopathic Parkinson’s…
  • 2024 International Congress

    Exploring Non-Invasive Wearable Devices in Home Settings for Assessment and Treatment of the Duration of ON and OFF State and Freezing of Gait in Parkinson’s Disease: A Case Study.

    V. Azoidou, A. Noyce, C. Simonet, A. Mackett (London, United Kingdom)

    Objective: To assess the effect of cueing with vibrotactile stimulation on the duration of ON and OFF state and freezing of gait (FOG) in patients…
  • 2024 International Congress

    Studying digenic Parkinson’s disease in a stem cell model carrying mutant p.N409S in the GBA1 gene and the homozygous deletion of exon 3 PARK2

    C. Oleksy, Z. Hanss, F. Massart, G. Arena, I. Boussaad, R. Krüger (Belvaux, Luxembourg)

    Objective: We aim to study the combined effect of the GBA1 p.N409S mutation and a complete loss of Parkin based on a patient-based stem cell…
  • 2024 International Congress

    MRI Predictive Marker of the Vestibular Galvanic Stimulation Effectiveness in the Postural Instability Treatment in Parkinson’s Disease.

    O. Alenikova, A. Chumak A, G. Zobnina, D. Antonenka (Minsk, Belarus)

    Objective: To assess the galvanic vestibular stimulation (GVS) effect on axial symptoms and cervical vestibular evoked myogenic potential (cVEMP) depending on the Magnetic Resonance Parkinsonism…
  • 2024 International Congress

    Focused Ultrasound Therapy Treatment for Parkinson’s Disease

    Z. Muttalib, B. Syed, M. Alam, D. Nadora, U. Ansari, R. Sedighi, A. Vemulapalli, S. Asad (Elk Grove, USA)

    Objective: Parkinson’s Disease is a neurodegenerative disease that mainly affects the substantia nigra and nigrostriatal pathway and leads to rigidity, loss of muscle tone, tremors,…
  • 2024 International Congress

    Clinical and Imaging Changes in Parkinson’s Disease Patients Under Spinal Cord Stimulation: A Double Blinded Analysis

    R. Carra, L. Garcia, J. Menezes, T. Capato, E. Barbosa, K. Duarte, M. Teixeira, R. Cury (Sao Paulo, Brazil)

    Objective: Evaluate clinical and biomarker changes from spinal cord stimulation (SCS) in Parkinsons Disease (PD) under sham controlled randomized evaluation. Background: SCS has been proposed…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 33
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley